SA
AQST logo
Aquestive Therapeutics, Inc.(AQST)
Updated 12:04 PM ETAbout this dataData status
$3.77▼-0.14 (-3.58%)

AQST stories

written from corroborating sources
  • Aquestive Therapeutics Reports Q2 2026 Financial Results With $5.2 Million Revenue

    Aquestive Therapeutics reported a revenue of $5.2 million for the second quarter of 2026, reflecting a significant increase compared to the previous year. The company also provided a business update, highlighting ongoing developments in its product pipeline and strategic initiatives.

    Earnings·2 articles / 2 outlets·96d ago·◆ Primary source

More AQST headlines

1 article

Latest story Refreshed every 5 minutes; wire stories every 15 minutesAbout this data

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.